POST Online Media Lite Edition


Pfizer to stop manufacturing operations in Chennai, Aurangabad

Staff Writer |
Pfizer has decided to shut down its manufacturing units in Irungattukottai, Chennai and Aurangabad, Maharashtra, which came to it through an acquisition of injectables manufacturer Hospira in 2015.

Article continues below

Over 1,700 employees working in these two factories are expected to be impacted by the decision.

While the company is shutting down the two facilities, plans are afoot to expand the Vizag manufacturing facility, which also came as part of the acquisition.

Pfizer said that it conducted a thorough evaluation of the Irungattukottai and Aurangabad sites and concluded that due to a significant fall in product demand, manufacturing at these sites is not viable.

“As a result, Pfizer is announcing that both the Aurangabad and Irungattukottai sites will immediately cease manufacturing with the intention to exit both sites as soon as possible in 2019. The exact timing of the exit of the sites is to be determined,” said a Pfizer spokesperson.

What to read next

Pfizer officially withdraws from AstraZeneca deal
Pfizer starts work on new facility in Chesterfield, Mo.
Pfizer thinking about consumer healthcare business sale